Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit

We report the case of a 34-year-old woman affected by breast cancer that had metastasized to the bone. She had been treated with oral cyclophosphamide and methotrexate (metronomic chemotherapy) and achieved 3.5 years of clinical remission. To our knowledge, this is the first description of such a pr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Masci, G, Losurdo, A, Gandini, C, Garassino, I, di Tommaso, L, Torrisi, R, Zuradelli, M, Santoro, A
Format: Artigo
Idioma:Inglês
Publicat: Cancer Intelligence 2012
Matèries:
Case Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3484813/
https://ncbi.nlm.nih.gov/pubmed/23130087
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3332/ecancer.2012.275
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars